XLK-18300-59238
3 vaccinations
4 coded responses
30 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 209 / MD
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Dose 1 — Pfizer-BioNTech
-
2021-04-16
Registered in v-safe
-
2021-04-16
Dose 2 — Pfizer-BioNTech
-
2021-04-16
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Fever · Chills · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-04-22
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-07-16
- 2021-10-16
-
2021-12-01
Dose 3 — Pfizer-BioNTech
-
2021-12-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-12-03
Survey response — days 1–6 daily, dose 3MedDRA: Insomnia — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessFree text: Difficulty sleepingMedDRA releases: 2024-11 · check-in free text available
-
2021-12-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-05
-
2021-12-06
Survey response — days 1–6 daily, dose 3MedDRA: Insomnia — Feeling: Good · Site: ItchingFree text: Difficulty sleepingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-07
-
2021-12-08
Survey response — day 7, dose 3MedDRA: Insomnia — Feeling: GoodFree text: Difficulty sleepingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-15
- 2021-12-22
- 2021-12-29
-
2022-01-05
Survey response — day 35, dose 3MedDRA: Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headaches FatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-01-12
- 2022-03-02
- 2022-06-01
- 2022-12-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Difficulty sleeping
Systemic reaction (other): Difficulty sleeping
Release 10 — day 7, dose 3
Systemic reaction (other): Difficulty sleeping
Release 10 — day 35, dose 3
Symptoms: Headaches Fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release